Outbreak Investigation

FDA Reports Conditions Observed at New England Compounding Center Facility

The Food and Drug Administration (FDA) has released a copy of the FDA Form 483 issued to the New England Compounding Center (NECC). The FDA observed and has since confirmed contaminated products and listed a number of observations regarding conditions in the clean room at ...More
October 26, 2012
Posted in News
CDC Blog Explores Fungal Meningitis Outbreak

Imagine a patient goes to the doctor for a routine steroid injection. Several weeks later, the patient feels sick – headache, fever and suddenly uncomfortable in bright light. Within days, the patient is admitted to the local hospital’s intensive care unit. Doctors discover ...More
October 24, 2012
Posted in News
Investigation Report of NECC Released, Details Noncompliance with Clean Room Protocols

The Executive Office of Health and Human Services of the Massachusetts Department of Public Health (MDPH) today issued a report on its preliminary findings in its investigation of New England Compounding Center (NECC). Since Sept. 24, 2012 a widespread outbreak of fungal ...More
October 23, 2012
Posted in News
Update on the Multistate Fungal Meningitis Outbreak

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are currently coordinating a multistate investigation of fungal infection among patients who received a steroid injection with a potentially contaminated product either into the ...More
October 18, 2012
Posted in News
What We Know and Don't Know About the Fungal Meningitis Outbreak

In a new perspective piece being published online first in Annals of Internal Medicine, a physician recalls lessons learned from treating patients affected by the 2002 outbreak of Exophiala (Wangiella) dermatitidis meningitis or arthritis related to contaminated, injectable ...More
October 18, 2012
Posted in News
Additional NECC Product Implicated in Fungal Meningitis Outbreak Investigation

As a result of FDA, CDC and state health departments’ ongoing investigation of contamination at the New England Compounding Center’s (NECC) Framingham, Mass. facility, on Oct. 4, the FDA advised providers to not use any NECC products. On Oct. 6, NECC announced a recall of ...More
October 15, 2012
Posted in News
Slide Show: Meningitis Q&A for Clinicians

We present information for clinicians related to the ongoing investigation by the CDC, the FDA and state health departments of a multi-state meningitis outbreak of fungal infections. ...More
October 15, 2012
Posted in Galleries
Nearly 14,000 Patients Exposed to Recalled Lots of Contaminated Methylprednisolone Acetate

In an update from the Centers for Disease Control and Prevention (CDC) on Oct. 11, 2012, J. Todd Weber, MD, incident manager of the multistate meningitis outbreak and chief of the Prevention and Response Branch of the Division of Healthcare Quality Promotion at the CDC, ...More
October 12, 2012
Posted in News
New England Compounding Center Establishes Recall Operations Center

New England Compounding Pharmacy, Inc. (doing business as New England Compounding Center -- NECC) announces that it has established a Recall Operations Center to process and manage the removal of all NECC products from circulation. As a precautionary measure, due to the ...More
October 11, 2012
Posted in News
Update on Multistate Meningitis Outbreak Investigation

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are currently coordinating a multistate investigation of fungal meningitis among patients who received an epidural steroid injection with a potentially contaminated product. ...More
October 10, 2012
Posted in News